SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-23-004387
Filing Date
2023-08-11
Accepted
2023-08-11 17:00:32
Documents
1
Period of Report
2023-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 12375
  Complete submission text file 0000902664-23-004387.txt   14253
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Issuer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Reporting) CIK: 0001727492 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34703 | Film No.: 231165022

Mailing Address 590 MADISON AVENUE NEW YORK NY 10022
Business Address
JOHNSON DAVID EDWARD (Reporting) CIK: 0001785557 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34703 | Film No.: 231165021